Dry Eye Disease Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

December 05 17:03 2022
Dry Eye Disease Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market
DelveInsight Business Research LLP
DelveInsight’s “Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Dry Eye Disease Disease, historical and forecasted epidemiology as well as the Dry Eye Disease Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight’s Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2032″  report delivers an in-depth understanding of the Dry Eye Disease Disease, historical and forecasted epidemiology as well as the Dry Eye Disease Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Dry Eye Disease Disease market report provides current treatment practices, emerging drugs, Dry Eye Disease Disease market share of the individual therapies, and current and forecasted Dry Eye Disease Disease market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Dry Eye Disease Disease treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Dry Eye Disease Disease market

Some of the key facts of the Dry Eye Disease Market:

  • One study found that 17% of 2,127 patients visiting a hospital in Japan were diagnosed with Dry Eye Diseases, while 14.6% in a group of 2,520 older individuals reported symptoms of Dry Eye Diseases. Dry Eye Disease syndrome can occur at any age, and in otherwise healthy people. It is more common with older age when the individual produces fewer tears. It is also more common in women than in men.

  • According to the Association of Optometrists, Dry Eye Disease is a very common condition in the UK, affecting one in four people in the UK.

 

Got queries? Click here to know more about the Dry Eye Disease Market Landscape

 

 

Dry Eye Disease Overview

Dry Eye Disease disease (DED), also known as Dry Eye Disease syndrome (DES) or keratoconjunctivitis sicca (KCS), is a common condition when eyes do not produce enough tears or the tears evaporate too quickly. As tears are essential to lubricate and nourish the eye, the condition leads to eyes drying out and becoming red, swollen, and irritated. Causes for DED include decreased tear production, excessive tear evaporation, and abnormality in the production of mucus or lipids of the tear layer. It is caused by a chronic lack of sufficient lubrication and moisture on the surface of the eye. Consequences of Dry Eye Diseases range from subtle but constant eye irritation to significant inflammation and even scarring of the front surface of the eye. It can affect one or both eyes, and it can lead to inflammation.

The main symptom of Dry Eye Disease is a dry and gritty feeling in the eyes. The additional symptoms include burning or itching in the eyes, foreign body sensation, excess tearing, pain and redness of the eyes, and photophobia in some cases. Sometimes, it is also associated with a stringy discharge and blurred, changing vision. Besides, the symptoms are found to worsen in dry weather, with low humidity, and higher temperatures. Having Dry Eye Diseases for a while can lead to tiny abrasions on the surface of the eyes. In advanced cases, the epithelium undergoes pathologic changes, namely squamous metaplasia and loss of goblet cells. 

 

Dry Eye Disease Epidemiology Insights

 

  • According to a study conducted by Farrand et. al (2017), based on weighted estimates, 6.8% of the US adult population was projected to have diagnosed DED. Prevalence increased with age (18-34 years: 2.7%; ≥75 years: 18.6%) and was higher among women (8.8%) than men (4.5%). After adjustment, there were no substantial differences in prevalence/risk of diagnosed DED by race, education, or US census region.

  • According to Dana et al. (2019), the overall DED prevalence was 5.28%, wherein the prevalence among females and males was about 7.78% and 2.96%, respectively, in the US. Besides, the prevalence increased with age from 0.20%, for ages 2–17 years, to 11.66% for individuals aged above 50.

  • According to a study by Dalton et. al (2019), around 16 million Americans have been diagnosed with DED, but the actual number of Americans suffering from Dry Eye Disease symptoms is likely much higher. Some reports indicate that nearly half of all U.S. adults experience Dry Eye Disease signs and symptoms, and 33% of patients in eye care clinics present with complaints about Dry Eye Disease.

 

Dry Eye Disease Epidemiology Segmentation

 

  •  Dry Eye Disease prevalent cases 

  • Dry Eye Disease type-specific cases 

  • Dry Eye Disease diagnosed cases 

  • Dry Eye Disease age-specific cases

  • Dry Eye Disease gender-specific cases

  • Dry Eye Disease severity- specific cases 

 

Dry Eye Disease Market Outlook 

The Dry Eye Disease Disease market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Dry Eye Disease Disease market trends by analyzing the impact of current Dry Eye Disease Disease therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Dry Eye Disease Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Dry Eye Disease Disease market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Dry Eye Disease Disease market in 7MM is expected to witness a major change in the study period 2019-2032.

 Learn more by requesting for sample @ Dry Eye Disease Market Trends

 

 Dry Eye Disease Key Companies 

  • Palatin Technologies

  • Novaliq

  • mc2 therapeutics

  • And many others 

Dry Eye Disease Therapies

  • PL9643

  • NOV03

  • CyclASol

  • MC2-03

  • And many others 

 

Table of Contents

 

  1.   Key Insights 

  2.  Report Introduction 

  3.  Executive Summary of Dry Eye Disease   

  4.  Disease Background and Overview

  5.  Epidemiology and patient population

  6.  The United States 

  7.  EU 5

  8.  Dry Eye Disease     Emerging Therapies

  9.  Dry Eye Disease   Market Outlook

  10.  Market Access and Reimbursement of Therapies

  11.  Market Drivers 

  12.  Market Barriers 

  13.  Appendix

  14.  Dry Eye Disease   Report Methodology

  15.  DelveInsight Capabilities

  16.  Disclaimer

Click here to read more about Eye Disease Market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/